| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | recognition of apoptotic cell | 8.45e-05 | 7 | 42 | 2 | GO:0043654 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | 8.55e-05 | 929 | 42 | 9 | GO:0009792 | |
| GeneOntologyBiologicalProcess | semicircular canal morphogenesis | 1.44e-04 | 9 | 42 | 2 | GO:0048752 | |
| GeneOntologyBiologicalProcess | artery development | 1.53e-04 | 133 | 42 | 4 | GO:0060840 | |
| GeneOntologyBiologicalProcess | outer ear morphogenesis | 1.80e-04 | 10 | 42 | 2 | GO:0042473 | |
| GeneOntologyBiologicalProcess | semicircular canal development | 2.20e-04 | 11 | 42 | 2 | GO:0060872 | |
| GeneOntologyBiologicalProcess | embryonic skeletal system development | 2.30e-04 | 148 | 42 | 4 | GO:0048706 | |
| MousePheno | retroesophageal right subclavian artery | 2.98e-05 | 22 | 39 | 3 | MP:0004160 | |
| MousePheno | abnormal astrocyte physiology | 5.61e-05 | 27 | 39 | 3 | MP:0008916 | |
| MousePheno | aberrant origin of the right subclavian artery | 1.03e-04 | 33 | 39 | 3 | MP:0010465 | |
| MousePheno | absent cochlea | 1.13e-04 | 6 | 39 | 2 | MP:0003147 | |
| MousePheno | abnormal aortic arch and aortic arch branch attachment | 1.46e-04 | 37 | 39 | 3 | MP:0010464 | |
| MousePheno | absent vestibular saccule | 1.58e-04 | 7 | 39 | 2 | MP:0004315 | |
| MousePheno | increased hindbrain apoptosis | 1.58e-04 | 7 | 39 | 2 | MP:0012261 | |
| MousePheno | abnormal right subclavian artery morphology | 1.85e-04 | 40 | 39 | 3 | MP:0010487 | |
| MousePheno | absent endolymphatic duct | 2.10e-04 | 8 | 39 | 2 | MP:0000041 | |
| MousePheno | absent posterior semicircular canal | 2.70e-04 | 9 | 39 | 2 | MP:0003163 | |
| MousePheno | absent parathyroid glands | 2.70e-04 | 9 | 39 | 2 | MP:0000680 | |
| MousePheno | abnormal brainstem morphology | 3.97e-04 | 227 | 39 | 5 | MP:0005277 | |
| MousePheno | absent stapes | 4.11e-04 | 11 | 39 | 2 | MP:0004204 | |
| MousePheno | abnormal common crus morphology | 4.11e-04 | 11 | 39 | 2 | MP:0004922 | |
| MousePheno | abnormal endocrine gland physiology | 4.65e-04 | 363 | 39 | 6 | MP:0013561 | |
| MousePheno | abnormal subclavian artery morphology | 5.02e-04 | 56 | 39 | 3 | MP:0003395 | |
| Domain | - | 2.27e-05 | 74 | 42 | 4 | 3.40.50.410 | |
| Domain | VWF_A | 7.12e-05 | 99 | 42 | 4 | IPR002035 | |
| Domain | Sec23/24_helical_dom | 7.36e-05 | 6 | 42 | 2 | IPR006900 | |
| Domain | Sec23/24_trunk_dom | 7.36e-05 | 6 | 42 | 2 | IPR006896 | |
| Domain | Znf_Sec23_Sec24 | 7.36e-05 | 6 | 42 | 2 | IPR006895 | |
| Domain | Sec23_24_beta_S | 7.36e-05 | 6 | 42 | 2 | IPR012990 | |
| Domain | zf-Sec23_Sec24 | 7.36e-05 | 6 | 42 | 2 | PF04810 | |
| Domain | Sec23_trunk | 7.36e-05 | 6 | 42 | 2 | PF04811 | |
| Domain | Sec23_helical | 7.36e-05 | 6 | 42 | 2 | PF04815 | |
| Domain | Sec23_BS | 7.36e-05 | 6 | 42 | 2 | PF08033 | |
| Domain | RFX_DNA_binding | 1.76e-04 | 9 | 42 | 2 | PF02257 | |
| Domain | DNA-bd_RFX | 1.76e-04 | 9 | 42 | 2 | IPR003150 | |
| Domain | RFX_DBD | 1.76e-04 | 9 | 42 | 2 | PS51526 | |
| Domain | Gelsolin | 4.42e-04 | 14 | 42 | 2 | PF00626 | |
| Domain | Gelsolin-like_dom | 4.42e-04 | 14 | 42 | 2 | IPR007123 | |
| Domain | EMI_domain | 5.81e-04 | 16 | 42 | 2 | IPR011489 | |
| Domain | EMI | 6.57e-04 | 17 | 42 | 2 | PS51041 | |
| Domain | - | 1.32e-03 | 24 | 42 | 2 | 3.40.20.10 | |
| Domain | ADF-H/Gelsolin-like_dom | 1.32e-03 | 24 | 42 | 2 | IPR029006 | |
| Domain | Laminin_EGF | 2.80e-03 | 35 | 42 | 2 | PF00053 | |
| Domain | EGF_Lam | 2.80e-03 | 35 | 42 | 2 | SM00180 | |
| Domain | C2 | 3.17e-03 | 131 | 42 | 3 | PF00168 | |
| Domain | Laminin_EGF | 3.30e-03 | 38 | 42 | 2 | IPR002049 | |
| Domain | C2 | 3.60e-03 | 137 | 42 | 3 | SM00239 | |
| Domain | LDLR_class-A_CS | 3.65e-03 | 40 | 42 | 2 | IPR023415 | |
| Domain | C2 | 3.98e-03 | 142 | 42 | 3 | PS50004 | |
| Domain | - | 4.46e-03 | 148 | 42 | 3 | 2.60.40.150 | |
| Domain | Ldl_recept_a | 4.60e-03 | 45 | 42 | 2 | PF00057 | |
| Domain | - | 4.80e-03 | 46 | 42 | 2 | 4.10.400.10 | |
| Domain | LDLRA_1 | 5.22e-03 | 48 | 42 | 2 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 5.43e-03 | 49 | 42 | 2 | IPR002172 | |
| Domain | LDLa | 5.43e-03 | 49 | 42 | 2 | SM00192 | |
| Domain | CUB | 5.43e-03 | 49 | 42 | 2 | PF00431 | |
| Domain | LDLRA_2 | 5.43e-03 | 49 | 42 | 2 | PS50068 | |
| Domain | CUB | 5.65e-03 | 50 | 42 | 2 | SM00042 | |
| Domain | C2_dom | 5.94e-03 | 164 | 42 | 3 | IPR000008 | |
| Domain | - | 6.10e-03 | 52 | 42 | 2 | 2.60.120.290 | |
| Domain | CUB | 6.33e-03 | 53 | 42 | 2 | PS01180 | |
| Domain | CUB_dom | 7.29e-03 | 57 | 42 | 2 | IPR000859 | |
| Domain | EGF_extracell | 8.05e-03 | 60 | 42 | 2 | IPR013111 | |
| Domain | EGF_2 | 8.05e-03 | 60 | 42 | 2 | PF07974 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 3.63e-06 | 180 | 45 | 5 | 35198878 | |
| Pubmed | 9.81e-06 | 4 | 45 | 2 | 10940892 | ||
| Pubmed | Jedi-1 and MEGF10 signal engulfment of apoptotic neurons through the tyrosine kinase Syk. | 9.81e-06 | 4 | 45 | 2 | 22993420 | |
| Pubmed | The role of the C-terminal domain of PCSK9 and SEC24 isoforms in PCSK9 secretion. | 9.81e-06 | 4 | 45 | 2 | 32058034 | |
| Pubmed | Identification and characterization of novel human tissue-specific RFX transcription factors. | 9.81e-06 | 4 | 45 | 2 | 18673564 | |
| Pubmed | The gene encoding the central cannabinoid receptor is located in proximal mouse Chromosome 4. | 1.63e-05 | 5 | 45 | 2 | 8835542 | |
| Pubmed | 1.89e-05 | 650 | 45 | 7 | 38777146 | ||
| Pubmed | 2.45e-05 | 6 | 45 | 2 | 10075675 | ||
| Pubmed | 2.45e-05 | 6 | 45 | 2 | 10329445 | ||
| Pubmed | 2.45e-05 | 6 | 45 | 2 | 33811915 | ||
| Pubmed | Selective export of human GPI-anchored proteins from the endoplasmic reticulum. | 3.42e-05 | 7 | 45 | 2 | 20427317 | |
| Pubmed | Glial precursors clear sensory neuron corpses during development via Jedi-1, an engulfment receptor. | 3.42e-05 | 7 | 45 | 2 | 19915564 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 4.20e-05 | 497 | 45 | 6 | 36774506 | |
| Pubmed | 4.56e-05 | 8 | 45 | 2 | 17174946 | ||
| Pubmed | SEC24A deficiency lowers plasma cholesterol through reduced PCSK9 secretion. | 4.56e-05 | 8 | 45 | 2 | 23580231 | |
| Pubmed | FOXF2 is required for cochlear development in humans and mice. | 5.86e-05 | 9 | 45 | 2 | 30561639 | |
| Pubmed | 7.32e-05 | 10 | 45 | 2 | 25078604 | ||
| Pubmed | The transport signal on Sec22 for packaging into COPII-coated vesicles is a conformational epitope. | 7.32e-05 | 10 | 45 | 2 | 17499046 | |
| Pubmed | Structural basis of cargo membrane protein discrimination by the human COPII coat machinery. | 7.32e-05 | 10 | 45 | 2 | 18843296 | |
| Pubmed | 8.11e-05 | 1442 | 45 | 9 | 35575683 | ||
| Pubmed | Homeobox genes: a link between development, cell cycle, and cancer? | 8.94e-05 | 11 | 45 | 2 | 10328847 | |
| Pubmed | Planar cell polarity defects and defective Vangl2 trafficking in mutants for the COPII gene Sec24b. | 1.07e-04 | 12 | 45 | 2 | 20215345 | |
| Pubmed | 1.10e-04 | 191 | 45 | 4 | 31177093 | ||
| Pubmed | Genome-wide association scan of the time to onset of attention deficit hyperactivity disorder. | 1.27e-04 | 13 | 45 | 2 | 18937294 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 3.04e-04 | 457 | 45 | 5 | 32344865 | |
| Pubmed | 3.06e-04 | 20 | 45 | 2 | 30596474 | ||
| Pubmed | 3.09e-04 | 101 | 45 | 3 | 10997877 | ||
| Pubmed | 3.36e-04 | 104 | 45 | 3 | 10470851 | ||
| Pubmed | Rfx6 directs islet formation and insulin production in mice and humans. | 3.38e-04 | 21 | 45 | 2 | 20148032 | |
| Pubmed | AP-2δ is a crucial transcriptional regulator of the posterior midbrain. | 4.82e-04 | 25 | 45 | 2 | 21858141 | |
| Pubmed | Gse1, a component of the CoREST complex, is required for placenta development in the mouse. | 4.82e-04 | 25 | 45 | 2 | 37019373 | |
| Pubmed | 5.22e-04 | 26 | 45 | 2 | 37060937 | ||
| Pubmed | The COPII cargo adapter SEC24C is essential for neuronal homeostasis. | 5.22e-04 | 26 | 45 | 2 | 29939162 | |
| Pubmed | 5.22e-04 | 26 | 45 | 2 | 21303848 | ||
| Pubmed | 6.06e-04 | 28 | 45 | 2 | 34963058 | ||
| Pubmed | 6.50e-04 | 29 | 45 | 2 | 16966370 | ||
| Pubmed | 6.50e-04 | 29 | 45 | 2 | 33298461 | ||
| Pubmed | 7.43e-04 | 31 | 45 | 2 | 22323290 | ||
| Pubmed | 8.43e-04 | 33 | 45 | 2 | 23583979 | ||
| Interaction | DTX2 interactions | 5.04e-07 | 330 | 44 | 8 | int:DTX2 | |
| Interaction | FBLN5 interactions | 2.43e-05 | 159 | 44 | 5 | int:FBLN5 | |
| Interaction | TRPC3 interactions | 5.06e-05 | 33 | 44 | 3 | int:TRPC3 | |
| Interaction | SULF1 interactions | 5.54e-05 | 34 | 44 | 3 | int:SULF1 | |
| Cytoband | 6p12.1 | 4.87e-04 | 33 | 45 | 2 | 6p12.1 | |
| GeneFamily | Regulatory factor X family | 6.91e-05 | 8 | 29 | 2 | 1153 | |
| GeneFamily | Cyclins|Mediator complex | 1.27e-03 | 33 | 29 | 2 | 1061 | |
| GeneFamily | Phospholipases | 2.06e-03 | 42 | 29 | 2 | 467 | |
| Coexpression | MIKKELSEN_IPS_ICP_WITH_H3K27ME3 | 2.21e-06 | 55 | 44 | 4 | M1970 | |
| Coexpression | MIKKELSEN_IPS_ICP_WITH_H3K27ME3 | 2.21e-06 | 55 | 44 | 4 | MM842 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B-GC_B_(II)|GI_large-bowel / Manually curated celltypes from each tissue | 1.36e-06 | 190 | 45 | 5 | fee64bacbb330d04dc1dc63909838f2c605d9f1f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-OPC_related|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.11e-05 | 137 | 45 | 4 | 264d5e06c37d1a9ef7748091b67d2a5aa803096e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-OPC_related-Oligodendrocyte/OPC|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.11e-05 | 137 | 45 | 4 | 8ce463d1d74ac0ce80b812217d6bd76a788f14d2 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.28e-05 | 142 | 45 | 4 | 66135fee18448cc09a78bc6ede05afd63c72ae21 | |
| ToppCell | tumor_Lung-B_lymphocytes-GC_B_cells_in_the_LZ|tumor_Lung / Location, Cell class and cell subclass | 1.85e-05 | 156 | 45 | 4 | b5851474ba14dd2b4867415828b52dd98ecdd6d3 | |
| ToppCell | Healthy_Control-Lymphoid-B-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.20e-05 | 163 | 45 | 4 | d84bd41b4494c7d5c7f88d511bfe481fb12f079d | |
| ToppCell | Healthy_Control-Lymphoid-B|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.20e-05 | 163 | 45 | 4 | 0f723ec2503afa1b3ebb0754972438ffb6e6179d | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-ABC_aged-B_memory|bone_marrow / Manually curated celltypes from each tissue | 2.26e-05 | 164 | 45 | 4 | 746833f74095c0f25ce76baf1069f1848c231933 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-B_cells-LZ_GC_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.48e-05 | 168 | 45 | 4 | 08eb1284f9b8bd3e0e4b21bfc2bbee01d35a0bd7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.48e-05 | 168 | 45 | 4 | 7abaddbcc55e44653d54aa15464266aa6bd5c9d2 | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic-B_cells-Cycling_B_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.54e-05 | 169 | 45 | 4 | 203971cceeba150d0e8891c92662545e84c77837 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-05 | 171 | 45 | 4 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-05 | 171 | 45 | 4 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.66e-05 | 171 | 45 | 4 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | Immune_cells-B_cell|Immune_cells / Lineage and Cell class | 2.72e-05 | 172 | 45 | 4 | b646894b691a99bf2742bd9da8e578dff0e87f1f | |
| ToppCell | Influenza_Severe-B_intermediate|Influenza_Severe / Disease group and Cell class | 2.84e-05 | 174 | 45 | 4 | 4276bdaac53aebd3084323a90ecde572d3177446 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.91e-05 | 175 | 45 | 4 | 90e29945aa861082c94bb4f331161adc3a6ef899 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.97e-05 | 176 | 45 | 4 | e4b21fd6a5e0c5950f27c3e1868318e48330ae5e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.04e-05 | 177 | 45 | 4 | bde307e67ad8e48a5ff4c0827015f4688f6b3e46 | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.11e-05 | 178 | 45 | 4 | da1695a936dbe3ca9ee3fb28ceb60511c47b35f8 | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic-B_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.11e-05 | 178 | 45 | 4 | 580fc1d45b82010c665a313b2e7a21e0116819ef | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.18e-05 | 179 | 45 | 4 | f65889bf1e41396979cce44a5e63f49dea2bbd9b | |
| ToppCell | normal_Lung-B_lymphocytes|normal_Lung / Location, Cell class and cell subclass | 3.18e-05 | 179 | 45 | 4 | 5b89193486100b6754c1c5eca3105ea955805eae | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.25e-05 | 180 | 45 | 4 | b514c55e52b46e8a1a2f09ed2c59a7683367a505 | |
| ToppCell | severe_influenza-B_intermediate|World / disease group, cell group and cell class (v2) | 3.39e-05 | 182 | 45 | 4 | e633a908a2fb30ed362cf22fbb8d6839f31f1751 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.46e-05 | 183 | 45 | 4 | 38a54216458ad57f356bb4ddf272e1af8036ddeb | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.46e-05 | 183 | 45 | 4 | 65f2a5895d166189a095cf7ea9dda171f0419b08 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.46e-05 | 183 | 45 | 4 | f4f453692da77cef666cc281c4883c9c6b279fd4 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.46e-05 | 183 | 45 | 4 | 6086a862ab35bc683af44c03ee14cbb08ab99945 | |
| ToppCell | BL-critical-LOC-Lymphoid-B_cell|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.69e-05 | 186 | 45 | 4 | 27d4c38b180e4ce2bf3e7c4ad3db3a2ffca05ca8 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.77e-05 | 187 | 45 | 4 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | Control-Lymphocyte-B-B_intermediate|Control / Disease, Lineage and Cell Type | 3.77e-05 | 187 | 45 | 4 | 90c9b1a51539838323325f563be4adf5fdf1b38f | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.85e-05 | 188 | 45 | 4 | aeecbc057dc823f8fcea8a98f18d213bacc7f4db | |
| ToppCell | distal-Hematologic-B_cell-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.26e-05 | 193 | 45 | 4 | 202dc5ec2437602c15658074728c5f5aeeab0466 | |
| ToppCell | normal_Pleural_Fluid-B_lymphocytes|normal_Pleural_Fluid / Location, Cell class and cell subclass | 4.35e-05 | 194 | 45 | 4 | a3192698248561462d8d3bdaeabdff563a07019f | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.35e-05 | 194 | 45 | 4 | 11709704079f24a730476572dc2f01e9d2226e2c | |
| ToppCell | Control-Lymphoid-pDC|Lymphoid / Condition, Lineage and Cell class | 4.35e-05 | 194 | 45 | 4 | 5f95a5a35f73222dbe2ca52cc580f4774f641403 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.35e-05 | 194 | 45 | 4 | 3a1f95639d5f239f001bd67d4213e8938e7f299d | |
| ToppCell | normal_Pleural_Fluid-B_lymphocytes-Follicular_B_cells|normal_Pleural_Fluid / Location, Cell class and cell subclass | 4.35e-05 | 194 | 45 | 4 | 678da250aa881ff29482bc464affca7a5f360dc5 | |
| ToppCell | distal-2-Hematologic-B_cell|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.53e-05 | 196 | 45 | 4 | 2587b5d83fb4f1c4a69894aa0f5f7cb3898faa09 | |
| ToppCell | distal-Hematologic-B_cell-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.62e-05 | 197 | 45 | 4 | cc1567c3c539edc152118fb957617f8d445132d9 | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / Treatment groups by lineage, cell group, cell type | 4.62e-05 | 197 | 45 | 4 | 038fd92750257d43d5e980fd06d77742b543f11a | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-B-B_intermediate|Influenza_Severe / Disease, condition lineage and cell class | 4.71e-05 | 198 | 45 | 4 | ab622fee61714471af3a7be0af356e8a484dcaff | |
| ToppCell | (54)_pDC|World / shred on Cell_type and subtype | 5.19e-05 | 203 | 45 | 4 | b8ba3e51770ff7b45cd02472f3e63aa4d5816f6f | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.03e-04 | 90 | 45 | 3 | 3817a5b0235e632d976ea565175bdbebbd959bf0 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.03e-04 | 90 | 45 | 3 | a528f5dcee1a356dea89ff2588d2e0f276f2d5fc | |
| ToppCell | facs-MAT-Fat-3m-Epithelial-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 93 | 45 | 3 | dbfaa7f23d25f5c286ab7ca3ca795b734cb95153 | |
| ToppCell | facs-MAT-Fat-3m-Epithelial-epithelial_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 93 | 45 | 3 | 0d6d1d8dd9c91ba31eb35a4b5979d087890936c1 | |
| ToppCell | facs-MAT-Fat-3m-Epithelial|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 93 | 45 | 3 | abffb1fd5a919b7c08e62e1c3c08a8dd8783a4ca | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-Like-AT1_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.25e-04 | 117 | 45 | 3 | f3c77b234e461566aac81ede0ef84008c9a9f51e | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_activate-7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.99e-04 | 129 | 45 | 3 | 58790c6eaa597b8e8209a0fbc970e9cffa10bca5 | |
| ToppCell | COVID-19-kidney-Epithelial_Doublet|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.06e-04 | 130 | 45 | 3 | 1ff28e9d3dc9a791e07d815f8fbb48f75d3f275b | |
| ToppCell | mild_COVID-19-B_cell|mild_COVID-19 / disease group, cell group and cell class (v2) | 3.20e-04 | 132 | 45 | 3 | 4b372483bc106aecc7b96a09131e1695e54e7dc4 | |
| ToppCell | 21-Trachea-Immune-Immune|Trachea / Age, Tissue, Lineage and Cell class | 3.34e-04 | 134 | 45 | 3 | 4f0465324cc5b443ebadb68aef63be79b74f6ff9 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-04 | 137 | 45 | 3 | 761cc0e2b4971e98f6d0691d4575b5cd208b602d | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_activate-7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.72e-04 | 139 | 45 | 3 | 693ca81f5831b63fe6148ac755631e09f67d0ebf | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_D|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.96e-04 | 142 | 45 | 3 | 4ac3b285adfe80c47861943cf8c6188106cb3ba8 | |
| ToppCell | mild_COVID-19-B_cell|World / disease group, cell group and cell class (v2) | 4.05e-04 | 143 | 45 | 3 | 4698cc877dda9b1ef7d6f18c9adc869ef791b1d8 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_D|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.56e-04 | 149 | 45 | 3 | 3e05711ad4a8c2e6ebe6f36b1cef8b17ec2a1708 | |
| ToppCell | PND07-28-samps-Mesenchymal-Pericyte-pericyte_F|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.65e-04 | 150 | 45 | 3 | 2d0d6dc07dcfe28e3d7694c52d15d17dae2fd47b | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-9|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.65e-04 | 150 | 45 | 3 | d9931507257c64ead4a53786e6822f51962c6015 | |
| ToppCell | PND07-28-samps-Mesenchymal-Pericyte|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.65e-04 | 150 | 45 | 3 | 5b111ec11a642d63fafa7e1422e36f81a2776531 | |
| ToppCell | frontal_cortex|World / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.83e-04 | 152 | 45 | 3 | f9c29d4568402ca07a717dbffb3ccc7f35c5fe56 | |
| ToppCell | Adult-Epithelial-basal_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.93e-04 | 153 | 45 | 3 | 9ee3e7f3f19a2474283c1c79045269686f35a541 | |
| ToppCell | Adult-Immune-dendritic_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.02e-04 | 154 | 45 | 3 | 64a4686586d08b1e9632dde917b472ac660de2d3 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.21e-04 | 156 | 45 | 3 | 6f8622716bad4e505f241a2a4ef953bf3fc6dbfa | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-B_cells-Cycling_B_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.21e-04 | 156 | 45 | 3 | 203ef22eb76bd2b829b027c30af0557080f4006c | |
| ToppCell | P28-Hematopoietic-Immune-immune_cell_unspecified|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.31e-04 | 157 | 45 | 3 | a70f93aff07b6b7a9efce33b12b024116648dc0a | |
| ToppCell | P28-Hematopoietic-Immune|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.31e-04 | 157 | 45 | 3 | b1f520b1e0ea7abb19d0dd27021eafbea0fd90cd | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBC1D26|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.41e-04 | 158 | 45 | 3 | 3d6295fe25e3b1fb4b6e83704c5bdbf86dc639b3 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_B-ABC_aged-B_naive|lymph-node_spleen / Manually curated celltypes from each tissue | 5.41e-04 | 158 | 45 | 3 | 7098847804dd90fa1dd74536e4e90f989b630fe4 | |
| ToppCell | COVID-naiveBc-|COVID / Condition, Cell_class and T cell subcluster | 5.51e-04 | 159 | 45 | 3 | 4e6783b0f69c0c70150f9f3594881dc1bac7038a | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-3|TCGA-Skin / Sample_Type by Project: Shred V9 | 5.51e-04 | 159 | 45 | 3 | fb222c42f66901852b01cec073ec0732245ee973 | |
| ToppCell | COVID-naiveBc|COVID / Condition, Cell_class and T cell subcluster | 5.51e-04 | 159 | 45 | 3 | 52cd36b4412f69a935b3f76da96c166a9481eb0c | |
| ToppCell | 10x5'-Lung-Lymphocytic_B-ABC_aged-B_memory|Lung / Manually curated celltypes from each tissue | 5.51e-04 | 159 | 45 | 3 | d3202ddc291b8686dbe67690df13c7daffec2199 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.61e-04 | 160 | 45 | 3 | 636127753e3a22831f39d4c8170df40901e4329d | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.61e-04 | 160 | 45 | 3 | cb8d0dc1a6c69c7a85c5fdd8f0f6cca1b73dfc63 | |
| ToppCell | CD8+_Memory_T_cell-FLU-1|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 5.82e-04 | 162 | 45 | 3 | 76f39935763848ea6e7917b2f9f1432c543063d9 | |
| ToppCell | 10x5'-blood-Lymphocytic_B-ABC_aged-B_memory|blood / Manually curated celltypes from each tissue | 6.03e-04 | 164 | 45 | 3 | 0424b23fc540580e7c15c50a7a03dff7c25014fa | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-MAIT|ICU-SEP / Disease, Lineage and Cell Type | 6.03e-04 | 164 | 45 | 3 | db863a44fc0dad5518c47fdbf64ea21d6f36f089 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.03e-04 | 164 | 45 | 3 | ea02ca343b2b28e437304de889e2ae1e315a1197 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_ETV4|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.14e-04 | 165 | 45 | 3 | 1121f78574b9fe64d966b7f8c9cbc4d59e9b6e5e | |
| ToppCell | Adult-Immune-dendritic_cell|Adult / Lineage, Cell type, age group and donor | 6.14e-04 | 165 | 45 | 3 | 073f52698dac1fe4edd7410865f81b30e1c7196a | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_naive-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.14e-04 | 165 | 45 | 3 | 8003fd2aa3f5c9d0e99054af4ad2d79a4a3c4829 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-04 | 165 | 45 | 3 | 80f82aaab48791cb06fcb2d8ed7821f162742385 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.14e-04 | 165 | 45 | 3 | 4e13fccd32029e2879e85f8966e582a46c09e4aa | |
| ToppCell | Influenza_Severe-B_memory|Influenza_Severe / Disease group and Cell class | 6.14e-04 | 165 | 45 | 3 | 51172acaeb667b34b8b8c7878d67cfa0c4a2dffc | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-04 | 165 | 45 | 3 | 93ed399b8c6278e5f1528c07758fb502d80a1a8b | |
| ToppCell | NS-control-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.14e-04 | 165 | 45 | 3 | 8b2d43d7c4ee07bd999bd51bc15117ce1fbb2d86 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.14e-04 | 165 | 45 | 3 | 37615622c736e43260c38016e7c9e565ac97a3e8 | |
| ToppCell | control-Myeloid-pDC|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.14e-04 | 165 | 45 | 3 | 243c74adf8d993ff92acbff2768bdc5a1693eca3 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.14e-04 | 165 | 45 | 3 | 640bb71e74a61df2fcb01ceeabe4c493ef836b21 | |
| ToppCell | nucseq-Immune-Hematopoietic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.14e-04 | 165 | 45 | 3 | f3df74b5763130c71c0a482a3a23f6b22acc2892 | |
| ToppCell | facs-Heart-RA-18m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-04 | 166 | 45 | 3 | fc2cf67311c86fda75b35fcd4768b6f6f14c59d0 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-04 | 166 | 45 | 3 | 3213466380becf0ee3d4d9a0776ccbb1ee4eccea | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.25e-04 | 166 | 45 | 3 | a1009d25c5a500f470e8edb04097ac47d4d72f3c | |
| ToppCell | -SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.25e-04 | 166 | 45 | 3 | bc9323de1373fdc0357e6bb46874f6c4787443a9 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.25e-04 | 166 | 45 | 3 | 5a6e3364d223829f66e8da7f3560d95fd8bb9b11 | |
| ToppCell | facs-Heart-RA-18m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-04 | 166 | 45 | 3 | 33a6876d06e26176135a73a77c19e634ec53f7ce | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.25e-04 | 166 | 45 | 3 | e25bcbb5b3ba453a6e2572637f2521a32223a3ad | |
| Disease | apolipoprotein A 1 measurement | 2.39e-04 | 848 | 44 | 7 | EFO_0004614 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 2.52e-04 | 206 | 44 | 4 | EFO_0004612, EFO_0020947 | |
| Disease | stroke, major depressive disorder | 3.66e-04 | 19 | 44 | 2 | EFO_0000712, MONDO_0002009 | |
| Disease | polycystic ovary syndrome (biomarker_via_orthology) | 4.48e-04 | 21 | 44 | 2 | DOID:11612 (biomarker_via_orthology) | |
| Disease | HIV-1 infection, Susceptibility to viral and mycobacterial infections | 4.48e-04 | 21 | 44 | 2 | EFO_0000180, Orphanet_391311 | |
| Disease | abdominal:gluteofemoral adipose tissue ratio measurement | 8.60e-04 | 29 | 44 | 2 | EFO_0803320 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 9.22e-04 | 291 | 44 | 4 | EFO_0008317, EFO_0020946 | |
| Disease | L-Selectin measurement | 9.83e-04 | 31 | 44 | 2 | EFO_0008202 | |
| Disease | gluteofemoral adipose tissue measurement | 1.01e-03 | 132 | 44 | 3 | EFO_0803317 | |
| Disease | pelvic organ prolapse | 1.10e-03 | 136 | 44 | 3 | EFO_0004710 | |
| Disease | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | 1.19e-03 | 312 | 44 | 4 | EFO_0004612, EFO_0010351 | |
| Disease | cortical thickness | 1.20e-03 | 1113 | 44 | 7 | EFO_0004840 | |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | 1.24e-03 | 315 | 44 | 4 | EFO_0004574, EFO_0004612 | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 1.24e-03 | 315 | 44 | 4 | EFO_0004612, EFO_0008591 | |
| Disease | brain measurement, neuroimaging measurement | 1.32e-03 | 550 | 44 | 5 | EFO_0004346, EFO_0004464 | |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 1.47e-03 | 330 | 44 | 4 | EFO_0004529, EFO_0004612 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QPAKYPLNNAYHTSS | 491 | Q9H6X2 | |
| LGYSSSSQQSSQYHP | 481 | Q9BWU1 | |
| FNSDSFASHPNYPYS | 306 | P42330 | |
| TYPSQINTDSFSSYP | 141 | P20073 | |
| PQSHSYYFLNSLLPN | 276 | P21854 | |
| ASPYFSTNHQYTPLH | 56 | Q7Z6R9 | |
| PEQYYQTFSPSSSHS | 331 | Q7Z5J4 | |
| YAPYHRSSAQYPFNS | 636 | Q33E94 | |
| YPTLPQANHDFYSTS | 686 | Q8HWS3 | |
| FSGSPYSHPQYSSYN | 341 | Q02548 | |
| TFSTPSYLQQYPHQL | 311 | Q9BY79 | |
| NSHYFTNPSYHTLTQ | 921 | Q96KG7 | |
| PATNLTFSSYYQHTS | 26 | Q9GZQ6 | |
| SYNSRAYPAAHSNPV | 1966 | Q86YW9 | |
| YTNYSPSFQGHVTIS | 76 | A0A0J9YXX1 | |
| PYTPSADSNSFHQYR | 1366 | Q2LD37 | |
| SAFASTYRQQPSYPQ | 161 | Q08397 | |
| YYSNPSYHTLSQCSP | 816 | Q5VY43 | |
| SGFNSSQQDYPSYPS | 206 | Q99502 | |
| NSSPYPAHYMTSSNT | 231 | Q99502 | |
| NHYNSYKSPFNHTTT | 596 | Q9HCJ2 | |
| SQNFSAPYSPYALNQ | 101 | P49639 | |
| ANDHSPSFPTLYYQS | 1926 | Q6V1P9 | |
| TFPHLSYSAYIPENN | 451 | Q9Y5H0 | |
| QPLSAYFINSSHNTY | 321 | Q01970 | |
| YPPNQGAFSTEQSHY | 6 | Q9H4R4 | |
| PSSVNYQVRHFDSPY | 1266 | Q6P158 | |
| DFNSYVQSPAYHSPQ | 371 | Q9NP62 | |
| FTYASHPHQQYSLPS | 391 | Q9NP62 | |
| TPPNSYAQHSYFGSF | 216 | Q92622 | |
| TSASQPYSSFVNHYN | 146 | O95487 | |
| NPSQSTSLHYMSPYQ | 341 | Q9HCH3 | |
| SSSQHGPSYDVYNPF | 116 | Q8N9U0 | |
| SLTTNHQYVSSGYPS | 166 | O95486 | |
| HQYVSSGYPSLQNSF | 171 | O95486 | |
| TPGTYLTSHNQASYT | 1061 | O75376 | |
| QYNHPNTATVAPFLY | 686 | Q8IVL1 | |
| SSFLPPVTSYNQTSY | 1176 | Q5VXU9 | |
| ASQNYPLTSNTVYSP | 276 | Q9UKZ4 | |
| QYSSQLLPFYESSPQ | 86 | O60733 | |
| HSSYLEPTSVTNFNY | 131 | Q9UK61 | |
| HQQPPTSCYYNSTLT | 116 | Q5GAN3 | |
| HNLYPKYNFSSTNPF | 1256 | O75970 | |
| TYPPSYNLTFHSSQN | 296 | Q9Y5Y6 | |
| SYLSHSQSYLPSSQA | 216 | P49750 | |
| NHSNSYLAYPGSLTS | 151 | Q5MNZ9 | |
| NASQHITPSYNYAPN | 241 | Q8IWU5 | |
| SYTQFPNSFYEPHQD | 421 | Q86Y07 | |
| HAYSYSQAASQPTNV | 281 | Q8NCN2 |